Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

IDH soars to $900m after London IPO

Shares in the Egyptian lab group Integrated Diagnostic Holdings (IDH) have rocketed 35% to $6 per share in the two weeks since its IPO in London. The IPO at the very top of its indicative price range, valued IDH at 13.8 times 2014 EBITDA. It is now worth over $900m – a historic EBITDA multiple of 17.
May 22, 2015

Labco imports Silicon Valley eHealth

Lab group Labco plans to offer its 25m European patients preventative ehealth, including genome data, by importing BaseHealth, a US online patient platform. We speak to BaseHealth founder and chief scientific officer Houssein Fakhrai-Rad and Labco’s project lead Emeli Masferrer i Fons.
May 22, 2015

Regina Maria auction as Medlife stake readies for sale

We look at the bidders for Regina Maria, the second largest Romanian outpatient and hospital group which is being sold by Advent International as investors ready the sale of a minority stake in MedLife, the largest group.
May 21, 2015

Care UK sells off three divisions

Care UK has sold its learning disabilities division to specialist care provider Lifeways Group, two weeks after the sale of its mental health unit to Partnerships in Care. Leonid Shapiro, managing partner and founder at Candesic, says the group is reshaping its strategy.
May 21, 2015

Report: Huge investor interest at Healthcare Europa 2015

Click here to see all the presentations from Healthcare Europa 2015 How is the private healthcare services sector in Europe and beyond changing? Healthcare Europa 2015 provided a snapshot of the sector. We report. The fifth Healthcare Europa conference saw delegate numbers double to 430 with streams for acute, dentistry, elderly care and diagnostics in […]
May 21, 2015

Orpea acquires Germany’s third largest rehabilitation operator Celenus Kliniken

Orpea, Europe's second largest residential care group, has acquired Celenus Kliniken, Germany’s third largest provider of rehabilitation and psychiatric services. German brokers say that prices have soared with reha and care home opcos up from four times EBITDA in 2013 to a base line of six times with some bidders not flinching at 8-10 times. We speak to Bruno de la Rochebrochard, equity research analyst at investment bank Bryan Garnier, about the deal and the sector.
May 21, 2015

Labco’s failure to IPO may impact Synlab process

Labco pulled its IPO earlier this month, blaming market volatility. We are told there was a lack of appetite from institutional investors. The failure is likely to affect Synlab, which is going into a process 1B.
May 21, 2015
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us